Here is a formal academic-style abstract:

This study examines the 2024 NCCN Clinical Practice Guidelines for Breast Cancer, highlighting the integral role of systemic therapy in managing nonmetastatic breast cancer. A multidisciplinary approach is emphasized, incorporating various oncology specialties to inform comprehensive treatment strategies. The guidelines provide evidence-based recommendations, optimizing patient outcomes through tailored systemic therapy regimens. By synthesizing current research and clinical expertise, the NCCN guidelines remain a cornerstone in breast cancer management.